Jpmorgan Chase & CO Semler Scientific, Inc. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Semler Scientific, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 2,182 shares of SMLR stock, worth $97,055. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,182
Previous 2,285
4.51%
Holding current value
$97,055
Previous $78,000
34.62%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SMLR
# of Institutions
87Shares Held
3.88MCall Options Held
0Put Options Held
0-
Cerity Partners LLC New York, NY1.35MShares$59.9 Million0.07% of portfolio
-
Black Rock Inc. New York, NY349KShares$15.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA312KShares$13.9 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX185KShares$8.24 Million0.0% of portfolio
-
Shariaportfolio, Inc. Lake Mary, FL154KShares$6.83 Million2.34% of portfolio
About Semler Scientific, Inc.
- Ticker SMLR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 6,800,580
- Market Cap $302M
- Description
- Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...